Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 5
1989 1
1990 4
1991 3
1992 2
1993 5
1994 1
1995 1
1996 1
1997 1
1998 1
1999 1
2000 1
2001 3
2002 3
2003 3
2004 6
2005 5
2006 7
2007 11
2008 8
2009 6
2010 9
2011 10
2012 12
2013 11
2014 11
2015 7
2016 12
2017 5
2018 5
2019 6
2020 7
2021 7
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Results by year

Filters applied: . Clear all
Page 1
LIM Kinases in Osteosarcoma Development.
Brion R, Regnier L, Mullard M, Amiaud J, Rédini F, Verrecchia F. Brion R, et al. Among authors: redini f. Cells. 2021 Dec 15;10(12):3542. doi: 10.3390/cells10123542. Cells. 2021. PMID: 34944050 Free PMC article. Review.
Ewing sarcoma from molecular biology to the clinic.
Dupuy M, Lamoureux F, Mullard M, Postec A, Regnier L, Baud'huin M, Georges S, Brounais-Le Royer B, Ory B, Rédini F, Verrecchia F. Dupuy M, et al. Among authors: redini f. Front Cell Dev Biol. 2023 Sep 11;11:1248753. doi: 10.3389/fcell.2023.1248753. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37752913 Free PMC article. Review.
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.
Marques Da Costa ME, Zaidi S, Scoazec JY, Droit R, Lim WC, Marchais A, Salmon J, Cherkaoui S, Morscher RJ, Laurent A, Malinge S, Mercher T, Tabone-Eglinger S, Goddard I, Pflumio F, Calvo J, Redini F, Entz-Werlé N, Soriano A, Villanueva A, Cairo S, Chastagner P, Moro M, Owens C, Casanova M, Hladun-Alvaro R, Berlanga P, Daudigeos-Dubus E, Dessen P, Zitvogel L, Lacroix L, Pierron G, Delattre O, Schleiermacher G, Surdez D, Geoerger B. Marques Da Costa ME, et al. Among authors: redini f. Commun Biol. 2023 Sep 18;6(1):949. doi: 10.1038/s42003-023-05320-0. Commun Biol. 2023. PMID: 37723198 Free PMC article.
Osteoprotegerin: multiple partners for multiple functions.
Baud'huin M, Duplomb L, Teletchea S, Lamoureux F, Ruiz-Velasco C, Maillasson M, Redini F, Heymann MF, Heymann D. Baud'huin M, et al. Among authors: redini f. Cytokine Growth Factor Rev. 2013 Oct;24(5):401-9. doi: 10.1016/j.cytogfr.2013.06.001. Epub 2013 Jul 1. Cytokine Growth Factor Rev. 2013. PMID: 23827649 Free article. Review.
Proteoglycans on bone tumor development.
Velasco CR, Colliec-Jouault S, Redini F, Heymann D, Padrines M. Velasco CR, et al. Among authors: redini f. Drug Discov Today. 2010 Jul;15(13-14):553-60. doi: 10.1016/j.drudis.2010.05.009. Epub 2010 May 27. Drug Discov Today. 2010. PMID: 20553958 Review.
SKCa- and Kv1-type potassium channels and cancer: Promising therapeutic targets?
Dupuy M, Gueguinou M, Potier-Cartereau M, Lézot F, Papin M, Chantôme A, Rédini F, Vandier C, Verrecchia F. Dupuy M, et al. Among authors: redini f. Biochem Pharmacol. 2023 Oct;216:115774. doi: 10.1016/j.bcp.2023.115774. Epub 2023 Sep 5. Biochem Pharmacol. 2023. PMID: 37678626 Free article. Review.
181 results